Treatments

Paxlovid: Major new study into whether it can treat long Covid

Wed, 2022-11-30 09:10 — mike kraft

Could Paxlovid treat long Covid? Major new study aims to find out Experts hope the antiviral may help those who have never fully recovered from Covid. NBC News

Paxlovid — the most widely-used medication that people can take at home to treat an active case of Covid — is now being studied as a potential treatment for those who have remained sick months or even years following infection.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Paxlovid: Major new study into whether it can treat long Covid
Log in or register to post comments

Uganda'extends Ebola epicentre's quarantine for 21 days

Mon, 2022-11-28 11:29 — mike kraft

Uganda's president extends Ebola epicentre's quarantine for 21 days Uganda's President Yoweri Museveni has extended a quarantine placed on two districts that are the epicentre of the country's Ebola outbreak by 21 days, adding that his government's response to the disease was succeeding. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Uganda'extends Ebola epicentre's quarantine for 21 days
Log in or register to post comments

Apixaban blood thinner treatment for COVID now considered dangerous--UK study

Mon, 2022-11-28 10:23 — mike kraft

Covid blood-thinner drug treatment dangerous and does not work – study UK government-backed Heal-Covid trial finds Apixaban can cause dangerous bleeding and does not improve prognosis the Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Apixaban blood thinner treatment for COVID now considered dangerous--UK study
Log in or register to post comments

Overview: China copes with dissent over lockdowns, plus research and other developments

Fri, 2022-11-25 11:39 — mike kraft

As COVID cases rise, China locks down despite criticism The restrictions are at the heart of the unrest in China as the country grapples with a rising number of infections after years of quarantine policies Jaimy Lee MarketWatch

The COVID-19 restrictions are at the heart of the unrest in China as the country grapples with a rising number of infections after years of quarantine policies.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Overview: China copes with dissent over lockdowns, plus research and other developments
Log in or register to post comments

Study finds a lower compliance rate with recently released guidelines for COVID-19 care

Wed, 2022-11-23 17:45 — mike kraft

Study finds a lower compliance rate with recently released guidelines for COVID-19 care Uptake of national guidelines for the treatment of children hospitalized with COVID-19 fell well below what would typically be expected, report researchers at the Medical University of South Carolina (MUSC) and elsewhere in Pediatrics. News-Medical.net

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Study finds a lower compliance rate with recently released guidelines for COVID-19 care
Log in or register to post comments

What Covid taught scientists and the public about the flu

Wed, 2022-11-23 10:12 — mike kraft

Key lessons we learned from Covid that scientists are now applying to the flu For nearly three years, the medical and scientific world scrutinized Covid. That research helped experts gain a new understanding of a much older virus: the flu. NBC News

...

Whether it was Covid’s dominance or behavioral changes that contributed most to the nonexistent 2020-2021 flu season — and many credit both — the newfound knowledge that flu transmission can in fact, be stopped, is here to stay.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about What Covid taught scientists and the public about the flu
Log in or register to post comments

New boosters add limited protection against Covid-19 illness-- first real-world study

Wed, 2022-11-23 09:51 — mike kraft

New boosters add limited protection against Covid-19 illness, first real-world study shows | CNN Updated Covid-19 boosters that carry instructions to arm the body against currently circulating Omicron subvariants offer some protection against infections, according to the first study to look at how the boosters are performing in the real world. However, the protection is not as high as that provided by the original vaccine against earlier coronavirus variants, the researchers say. Brenda Goodman CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about New boosters add limited protection against Covid-19 illness-- first real-world study
Log in or register to post comments

One dose of monkeypox vaccine yields strong protection --UK study

Tue, 2022-11-22 17:20 — mike kraft

U.K. analysis shows one dose of monkeypox vaccine yields strong protection An analysis released Tuesday by U.K. health officials indicates that even one dose of the monkeypox vaccine provides strong protection against the virus. Andrew Joseph STAT

...

Researchers at the U.K. Health Security Agency estimated that one dose of the vaccine was 78% effective at protecting against infection 14 or more days after vaccination.

...

Country / Region Tags:

General Topic Tags: